Immune Health in Space

12/04/2018BATON ROUGE – With a new crew arriving at the International Space Station, astronauts
will be relieved to know that they won’t have to worry about a major aspect of their
immune system being compromised. While researchers know a lot about astronauts’ skeletal
and muscular health during spaceflight and when they return to Earth, much less is
known about how spaceflight affects immunity. It has been generally thought, until
now, that spaceflight has a detrimental impact on all aspects of the immune system.

“Long-duration orbital spaceflights are associated with increased levels of psychological
stress, acute and chronic exposure to space radiation and microgravity-induced changes,
all of which are known to detrimentally impact the immune system. However, the effects
of spaceflight on B-cell immunity – a major arm of the immune system – has remained
unclear,” said Guillaume Spielmann, LSU School of Kinesiology assistant professor and co-author of a new study on spaceflight’s
effects on a major part of the immune system.

The successful implementation of exploration-class missions to Mars or other near-Earth
objects requires a better understanding of the impact of long-duration spaceflight
on the immune system in order to evaluate the risks of adverse health events associated
with immune dysregulations for the crew.

Until now, due to spaceflight’s logistical constraints, the majority of space immunology
has been conducted during short-duration missions or by comparing pre- to post-flight
measures of immune function. Last week, Spielmann and University of Bath Department
for Health’s John Campbell published their results from a long duration spaceflight study that aimed to shed
light on any alterations in human B-cell function in astronauts who lived on the International
Space Station, or ISS, for 6 months.

B-cells are an essential type of white blood cells responsible for producing antibodies
that will target harmful pathogens. Optimal B-cell immunity is crucial to ensure long-term
protection against disease-causing bacteria and viruses and is the cornerstone of
vaccine efficacy.

“This is the first study to comprehensively show that long-duration spaceflight in
human astronauts has limited effect on B-cell frequency and antibody production,”
Campbell said.

Blood samples were collected from astronauts before, during and after 6 months living
on the ISS. The results suggest that B-cell immune competency was unaffected by time
spent on the ISS. These findings may support the use of in-flight vaccine-based countermeasures
to protect astronauts from immune dysregulation and symptomatic latent viral reactivations
that are known to occur in longer duration missions, such as eventual travel to Mars.

This study provides novel insights on B-cell immunity during a 6-month mission in
the ISS. The team behind it suggest future studies are still required to ensure that
astronauts’ ability to produce functional antibodies will remain unaltered during
longer missions.

NASA Expedition 58-59: https://www.nasa.gov/mission_pages/station/expeditions/future.htmlNote: Lt. Col. Anne McClain, a University of Bath graduate, is aboard the Soyuz MS-11’s
for this week’s mission to the International Space Station. She received a Master
of Science degree in Aerospace Engineering from the University of Bath in Bath.